Cargando…
Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects
Empagliflozin (EMPA), a drug approved for type 2 diabetes management, reduced cardiovascular death but is unknown if it reduces myocardial infarction. We sought to investigate: (i) the effect of EMPA on myocardial function and infarct size after ischemia/reperfusion in mice fed with western diet (WD...
Autores principales: | Andreadou, Ioanna, Efentakis, Panagiotis, Balafas, Evangelos, Togliatto, Gabriele, Davos, Constantinos H., Varela, Aimilia, Dimitriou, Constantinos A., Nikolaou, Panagiota-Efstathia, Maratou, Eirini, Lambadiari, Vaia, Ikonomidis, Ignatios, Kostomitsopoulos, Nikolaos, Brizzi, Maria F., Dimitriadis, George, Iliodromitis, Efstathios K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742117/ https://www.ncbi.nlm.nih.gov/pubmed/29311992 http://dx.doi.org/10.3389/fphys.2017.01077 |
Ejemplares similares
-
Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes
por: Lambadiari, Vaia, et al.
Publicado: (2018) -
Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19
por: Ikonomidis, Ignatios, et al.
Publicado: (2020) -
Association of Hypoglycemia with Biomarkers of Oxidative Stress and Antioxidants: An Observational Study
por: Papachristoforou, Eleftheria, et al.
Publicado: (2022) -
Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12‐Month Treatment
por: Ikonomidis, Ignatios, et al.
Publicado: (2020) -
Elucidating Carfilzomib’s Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin
por: Efentakis, Panagiotis, et al.
Publicado: (2021)